Get the Stockscreener App
1.30
12.07%
0.14
After Hours:
1.34
0.04
+3.08%
Mira Pharmaceuticals Inc stock is traded at $1.30, with a volume of 1.57M.
It is up +12.07% in the last 24 hours and down -32.64% over the past month.
Mira Pharmaceuticals Inc is a pre-clinical-stage pharmaceutical development company with two neuroscience programs targeting a broad range of neurologic and neuropsychiatric disorders. The company's novel oral pharmaceutical marijuana, MIRA-55, is under investigation for treating adult patients suffering from anxiety and cognitive decline, often associated with early-stage dementia.
See More
Previous Close:
$1.16
Open:
$1.22
24h Volume:
1.57M
Relative Volume:
0.29
Market Cap:
$19.22M
Revenue:
-
Net Income/Loss:
$-7.54M
P/E Ratio:
-
EPS:
-
Net Cash Flow:
$-4.47M
1W Performance:
+22.64%
1M Performance:
-32.64%
6M Performance:
+18.18%
1Y Performance:
-72.04%
1-Day Range:
$1.18
$1.36
1-Week Range:
$1.05
$1.36
52-Week Range:
$0.51
$6.40
Mira Pharmaceuticals Inc Stock (MIRA) Company Profile
Name
Mira Pharmaceuticals Inc
Sector
Industry
Phone
813-369-5150
Address
1200 BRICKELL AVENUE, MIAMI
Mira Pharmaceuticals Inc Stock (MIRA) Latest News
Experts predict Mira Pharmaceuticals Inc’s (MIRA) current quarter earnings growth rate - US Post News
Mira Pharmaceuticals Inc’s latest rating changes from various analysts - Knox Daily
Why Mira Shares Are Trading Higher Today - MSN
Mira Pharmaceuticals (NASDAQ:MIRA) Stock Quotes, Forecast and News Summary - Benzinga
Why Mira Shares Are Trading Higher Today - Benzinga
A closer look at MIRA’s price-to-free cash flow ratio - US Post News
MIRA Pharmaceuticals Announces New Preclinical Data for Ketamir-2 to Be Presented at the 18th Annual Pain Therapeutics Summit in Boston on October 28-29, 2024 - The Hastings Tribune
MIRA Pharmaceuticals Announces New Preclinical Data for Ketamir-2 to Be Presented at the 18th Annual Pain Therapeutics Summit in Boston on October 28-29, 2024 - AccessWire
MIRA Pharmaceuticals Announces New Preclinical Data for Ketamir-2 to Be Presented at the 18th Annual Pain Therapeutics Summit in Boston on October 28-29, 2024 - StockTitan
MIRA Pharmaceuticals, Inc. (NASDAQ:MIRA) Short Interest Down 57.0% in September - Defense World
Meera Industries Ltd leads gainers in 'B' group - Business Standard
Check Out Mirion Technologies Inc. (MIR)’s Trade Data Rather Than the Analysts’ Views - SETE News
Mirum Pharmaceuticals (NASDAQ:MIRM) pulls back 3.7% this week, but still delivers shareholders stellar 31% CAGR over 5 years - Simply Wall St
Gabelli Funds LLC Lowers Holdings in Mirion Technologies, Inc. (NYSE:MIR) - Defense World
MIRAIT ONE Corporation Concludes Stock Buyback - TipRanks
A Look at Mirum Pharmaceuticals Inc (MIRM) Shares in the Recent Past Indicates Growth - SETE News
Is Healthpeak Properties Stock Underperforming The Dow? - Barchart
Walgreens Boots Alliance Stock: Is WBA Underperforming The Healthcare Sector? - Barchart
Coffee Prices Jump As Global Weather Concerns Persist - Barchart
Is Charles River Laboratories Stock Underperforming The Dow? - Barchart
Is Hologic Stock Outperforming The Nasdaq? - Barchart
Stocks Climb On Optimism Fed Can Achieve A Soft Landing - Barchart
Is News Corporation Stock Underperforming The Nasdaq? - Barchart
Stocks In Play: Canadian Pacific Kansas City - Barchart
OceanGate co-founder outlines the vision Titan company had for more accessible deep-sea travel before implosion - Barchart
Stocks In Play: CN - Barchart
Elon Musk Now Pays His Father's Bills Despite Growing Up With 'So Much Money We Couldn't Even Close Our Safe' - Barchart
MIRA Pharmaceuticals Aims To Transform Neuropathic Pain Treatment With Ketamir-2 - Barchart
Trulieve To Open Medical Cannabis Dispensary In Hudson, Florida - Barchart
REVIEW: MIRA ART FAIR - FAD magazine
MIRA Pharmaceuticals (NASDAQ:MIRA) Trading Down 3.4% - Defense World
Ontario Lottery and Gaming CorporationEVENING LOTTERY WINNING NUMBERSSept. 20, 2024 - Barchart
LiTHOS Announces Grant of RSUs and PSUs to Conserve Capital and Align Interests with Long-Term Growth - Barchart
Friedreich’s Ataxia Treatment Market Size in the 7MM will experience significant changes during the forecast period of 2024-2034, estimated DelveInsight - Barchart
Trump Media Skids To New Low On The First Day The Former President Can Sell His Shares - Barchart
Rain Forecasts For Brazil Send Coffee Prices Tumbling - Barchart
Is Biogen Stock Underperforming The Dow? - Barchart
Time To Buy These Highly Ranked Construction Stocks After Rate Cuts - Barchart
Trump Media plummets to new low on the first trading day the former president can sell his shares - Barchart
Stocks In Play: Aurora Cannabis Inc. - Barchart
Marvell (MRVL): Strong Industry, Solid Earnings Estimate Revisions - Barchart
West Pharmaceutical Stock: Is WST Underperforming The Healthcare Sector? - Barchart
Is Keysight Technologies Stock Underperforming The Dow? - Barchart
Union Pacific Issues Bullish Views On Operating Ratio & Revenue Growth - Barchart
Passenger on a previous Titan submersible dive testified his mission was aborted underwater due to apparent malfunction - Barchart
Axon Enterprise Stock: Is AXON Outperforming The Industrials Sector? - Barchart
3 Top Large Cap Stocks For A Stable Approach: ETN, DECK, UNH - Barchart
Orex Minerals Appoints New CEO And Board Director - Barchart
Grab This Gold Stock While It's Cheap - Barchart
Radiation Detection, Monitoring, and Safety Market: $4.4 Billion by 2029, CAGR 8.3% | MarketsandMarkets™ - Barchart
Sanofi Stock Up Almost 23% In 3 Months: Buy, Sell Or Hold? - Barchart
Mira Pharmaceuticals Inc Stock (MIRA) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.63%
0.03%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):